Start your gene search:
Accell siRNA
Accell siRNA achieves what no other product can claim: delivery into difficult-to-transfect cells without additional reagents, virus, or instruments. Achieve gene silencing in cells that had been beyond the reach of conventional RNAi methods due to toxicity from transfection reagents or undesirable viral responses.
Highlights
- Accell siRNA enters cells without the need for transfection reagents, virus (or viral vectors), or instruments.
- Novel siRNA modifications facilitate uptake, stability, specificity and knockdown efficiency.
- Proven performance in neuronal, immunological, primary, and other difficult-to-transfect cell types.
Experimental considerations
This breakthrough in siRNA delivery requires no transfection reagent, but has some unique application requirements.
- Accell siRNA works at a higher concentration than conventional siRNA; recommended 1µM working concentration.
- Delivery may be inhibited by the presence of BSA in serum. Optimization studies with serum-free media formulations (Accell Delivery Media) or < 2.5% serum in standard media is recommended.
- Full-serum media can be added back after 48 hours of incubation, optimal mRNA silencing is typically achieved by 72 hours, or up to 96 hours for protein knockdown.